SCHEMBL1665343

SCHEMBL1665343

CC(OC(=O)C1CCCCC1C(=O)O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.53
HCAR2 Q8TDS4 1/20 0.45
KCNQ3 O43525 1/20 0.44
KCNQ2 O43526 1/20 0.44
TSHR P16473 2/20 0.43
KDM4E B2RXH2 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 3/20 0.42
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
LMNA P02545 3/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C19 P33261 2/20 0.40
EPHX1 P07099 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665342 0.95 HCAR2 (0.49) TAAR1HCAR2KCNQ3KCNQ2TSHR
SCHEMBL2034469 0.84 HCAR2 (0.42) TAAR1HCAR2TSHRHSD17B10CYP2C19
SCHEMBL17766255 0.83 TAAR1 (0.49) TAAR1KCNQ3KCNQ2TSHRKDM4E
SCHEMBL17766293 0.83 TAAR1 (0.52) TAAR1KCNQ3KCNQ2TSHRKDM4E
SCHEMBL1667292 0.82 HCAR2 (0.40) TAAR1HCAR2KCNQ3KCNQ2TSHR
SCHEMBL2034468 0.82 HCAR2 (0.45) HCAR2TSHRHSD17B10LMNAMAPT
SCHEMBL1664724 0.82 POLB (0.45) TAAR1HCAR2TSHRKDM4EHSD17B10
SCHEMBL1665337 0.82 CHRM2 (0.44) TAAR1TSHRKDM4ERAB9ALMNA
SCHEMBL22791138 0.81 LMNA (0.58) HCAR2TSHRRECQLRAB9ALMNA
SCHEMBL3863050 0.81 SMN1; SMN2 (0.42) TSHRHSD17B10RAB9AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011071674-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-06-16 WO disclosed
EP-2307476-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-04-13 EP disclosed
US-20100113664-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2010-05-06 US disclosed
WO-2009152068-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2009-12-17 WO disclosed
US-20090312470-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312470-A1 Asymmetric Cyclic Diester Compounds DDT, PCNA, AADAC TAAR1 2173/4885HCAR2 1123/4885KCNQ3 3305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.